Scientists Uncover Breakthrough in Conquering Pancreatic Cancer’s Unyielding Barrier
Researchers at Sylvester Comprehensive Cancer Center have identified IL1RAP as a critical vulnerability in pancreatic cancer, paving the way for a first-of-its-kind neoadjuvant clinical trial combining the targeted approach with chemoimmunotherapy before surgery, according to findings published in JCI Insight. The planned trial targets the receptor to disrupt the complex inflammatory network surrounding tumors, offering … Read more